Why Big Pharma Gave Up on Alzheimer’s & Parkinson’s Research
Why did major pharmaceutical companies pull back from Alzheimer’s and Parkinson’s research — and could nutrition be part of what conventional medicine has overlooked?
In this episode, Kevin Davis sits down with Dr. John Lewis to explore Alzheimer’s disease, cognitive decline, chronic inflammation, immune function, and the nutrition research that changed the direction of his career.
Dr. Lewis shares the story behind his work at the University of Miami, including an Alzheimer’s study that produced statistically significant improvements in cognitive function. He also explains what researchers observed in inflammatory markers, immune-system balance, and adult stem-cell production — including a reported 286% increase in adult stem cells.
They discuss:
- Why Dr. Lewis believes the CD4-to-CD8 ratio is an important marker of immune health
- What his research found involving inflammatory markers such as TNF-alpha and VEGF
- The reported 286% increase in adult stem-cell production
- What happened during his Alzheimer’s and multiple sclerosis research that surprised clinicians
- How plant-based polysaccharides may influence immune function and cognitive health
- The connection between inflammation, nutrition, exercise, sleep, stress, alcohol, hydration, hormones, and long-term brain health
Why Dr. Lewis believes these strategies may matter not only for people facing cognitive decline, but also for anyone interested in performance, longevity, and staying mentally sharp
Kevin also brings the conversation into the real world: watching loved ones struggle with cognitive decline, managing stress, maintaining physical and mental performance as we age, and deciding what actually belongs in a lifelong health strategy.
Dr. John Lewis is the founder of Dr. Lewis Nutrition and creator of Daily Brain Care. His academic career includes more than 180 published papers, with research focused on nutrition, exercise, inflammation, immune function, and cognitive health.